Antimicrobial Evaluation for Respiratory and Infection Systems (AERIS) is a one-stop research platform supporting industrial partners from early discovery to clinical validation to accelerate development of novel antimicrobials, immunotherapies and diagnostics targeting respiratory infections. We enable pharma and biotech innovators to rapidly optimize and validate antimicrobial and diagnostic strategies and bring life-saving respiratory infection therapies closer to patients.Go to the service offer page for more info.